Bexin Hustenstiller Butamirat, Sirup

7680696880013 CH-69688 Sirup
Bexin Hustenstiller Butamirat, Sirup
Bexin Hustenstiller Butamirat, Sirup
Bexin Hustenstiller Butamirat, Sirup
1 / 3
google

Article details

Package size
200
Selling units
200
Measure
ml
Galenic form
Sirup
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/08/2025
Patient information leaflet
Français
26/08/2025
Patient information leaflet
Italien
26/08/2025
Summary of Product Characteristics
Allemand
26/08/2025
Summary of Product Characteristics
Français
26/08/2025
Summary of Product Characteristics
Italien
26/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.5 MGML Substance Wirkstoff (Principe actif)
(N/A)
415.1 MGML Substance HBESI
(N/A)
- Substance AIMDK
(N/A)
1.1325 MGML Substance HBESI
(N/A)
- Substance AIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.25 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69688
Drug name
Bexin Hustenstiller Butamirat, Sirup
Galenic form
SIRU
ATC Code
R05DB13
Authorization status
Z
Dispensing category
D
First authorization
06/03/2025
Authorization expiration date
05/03/2030
IT Number
03.01.2.
Domain
Human medicine
Field of application
Husten, insbesondere trockener Husten

Package details

Description (FR)
BEXINE Antitussif Butamirate siroup 1.5 mg/ml 200
Description (DE)
BEXIN Hustenstiller Butamirat Sirup 1.5 mg/ml 200
Market launch
03/09/2025
Narcotic (BTM)
No